comscoreScreening and Testing

Screening and Testing

228 Research news
Black Women Most Likely To Experience Biopsy Delays After Abnormal Mammogram

Women from various racial and ethnic backgrounds, particularly Black women, had a higher risk of biopsy delays after an abnormal mammogram than white women.

Adding Clinical Risk of Recurrence to Oncotype DX Score Can Help Make Chemotherapy Decisions for Younger Women With Early-Stage Breast Cancer

Considering information about the clinical risk of recurrence of early-stage breast cancer along with the Oncotype DX Recurrence Score results can help refine which women age 50 and younger diagnosed with early-stage hormone-receptor-positive, HER2-negative breast cancer that has not spread to the lymph nodes with a Recurrence Score of 16 to 25 will benefit from chemotherapy.

Research Confirms Women With Oncotype DX Recurrence Score of 11 or Lower Can Skip Chemotherapy

The prospective PlanB study has found that women with a Recurrence Score of 11 or lower who skipped chemotherapy based on the Recurrence Score had excellent 5-year survival rates.

MammaPrint Test Can Help Estimate Risk of Recurrence

A study suggests the MammaPrint test can help estimate the risk of recurrence after surgery for early-stage disease.

Task Force Mammography Recommendations Reignites Debate

The debate about the benefits of screening mammograms for women younger than 50 goes back at least as far as 1969.

Nov 19, 2009 | Screening and Testing
Measuring Circulating Tumor Cells May Help Determine Recurrence Risk

A test that measures circulating tumor cells in the blood may help doctors more accurately determine the risk of breast cancer recurrence.

Study Suggests Breast Cancer Screening Options for Women With ATM, CHEK2, and PALB2 Mutations

Women with ATM, CHEK2, or PALB2 mutations may benefit from starting annual breast cancer screening with MRI between the ages and 30 to 35 and an annual MRI and mammogram starting at age 40.

Two Mammograms Per Year Better Than One After Lumpectomy

New research suggests that having mammograms twice per year after lumpectomy finds a cancer recurrence (or a new cancer) earlier than only one mammogram per year after surgery.

Many Women Who Got Chest Radiation as Children Aren't Getting Needed Breast Cancer Screening

Many women treated for childhood cancer with chest radiation therapy aren't getting recommended breast cancer screening.

Regular Mammograms Find Cancers Early

Getting regular mammograms reduces the risk of advanced breast cancer.

Jun 20, 2007 | Screening and Testing
Study Reinforces Benefits of Mammograms for Younger Women

More than 70% of deaths from breast cancer are in women aged 40 to 49 who don't get regular mammograms, a large study suggests.

Sep 28, 2013 | Screening and Testing
Another Study Suggests 3-D Mammograms Find More Cancers

Study adds more evidence to research suggesting that 3-D mammograms find more cancers than traditional 2-D mammograms.

May 14, 2015 | Screening and Testing
Telephone Genetic Counseling Just As Good As Face-to-Face Counseling

A study has found that genetic counseling over the phone is equal to in-person genetic counseling for women at high risk for a genetic mutation that would raise their risk of breast or ovarian cancer.

Mammography Should Be Primary Tool to Diagnose Breast Cancer in Men With Symptoms

Ultrasound doesn't add benefits beyond mammograms in diagnosing male breast cancer.

Jan 6, 2017 | Screening and Testing
Women Who Receive False Positive Mammogram Results May Be More Likely to Delay Next Screening

Research suggests that women who receive false-positive mammogram results may be more likely to put off their next scheduled mammogram.

Feb 13, 2017 | Screening and Testing
Most Women Have Multigene Genetic Testing, but Not Until After Surgery

A study has found that most women now have multigene testing after a breast cancer diagnosis, but this genetic testing is happening later in the treatment plan than testing for only BRCA1 or BRCA2 mutations.

May 17, 2018 | Diagnosis and Screening and Testing
American Society of Breast Surgeons Issues Updated Breast Cancer Screening Guidelines

The American Society of Breast Surgeons' new breast cancer screening recommendations say women at average risk should start having annual mammograms at age 40.

Using MRI to Follow Previously Diagnosed Women Finds More Breast Cancers, but Leads to More Biopsies

MRI monitoring in women previously diagnosed with breast cancer finds more cancers than mammography, but also leads to more biopsies.

Young, High-Risk Women Benefit From Breast Self-Exam

Research shows that breast self-exam is an important cancer detection tool for young women, especially young women at high risk for breast cancer.

Apr 23, 2009 | Screening and Testing
Regular Screening Reduces Risk of Dying From Breast Cancer

Women diagnosed with breast cancer who had regular mammograms had a 60% lower risk of dying from the disease in the 10 years after diagnosis and a 47% lower risk of dying from the disease in the 20 years after diagnosis compared to women who didn't have regular screening.

Nov 14, 2018 | Screening and Testing
Biopsy of Metastatic Cancer May Change Treatment Plan

Research suggests that a breast cancer's characteristics may change if the cancer metastasizes, so doing a biopsy on metastatic cancer may make sense in some cases.

Young Adults With Early-Onset Cancer May Benefit From Genetic Testing

People age 18 to 39 who are diagnosed with cancers typically seen in older adults, such as breast cancer, have a higher-than-expected risk of having a genetic mutation linked to cancer and so might benefit from genetic testing.

Jun 24, 2020 | Diagnosis and Screening and Testing
3D Screening Mammograms Reduce Interval Breast Cancer Rate Compared to 2D Digital Mammograms

A Swedish study found 3D screening mammograms reduce the rate of interval cancers — cancers detected in between routine screening — compared to 2D digital mammograms.

Apr 15, 2021 | Screening and Testing
Genetic Testing Guidelines Need Revision Experts Say

Current genetic testing recommendations don't take into account women who have few female relatives and no family history of breast cancer.

Showing 24 of 228